天臣医疗前三季净利增近七成，陈望宇兄弟分任董事长和总经理、去年同薪

Financial Performance - The company reported a revenue of 244 million yuan for the first three quarters, representing a year-on-year increase of 20.66% [1] - The net profit attributable to shareholders was 71.95 million yuan, up 68.29% year-on-year [1] - The net profit excluding non-recurring items was 66.20 million yuan, reflecting a 71.85% increase compared to the previous year [1] - Basic earnings per share were 0.90 yuan [1] Profitability Metrics - The gross margin for the first three quarters was 63.22%, an increase of 5.02 percentage points year-on-year [1] - The net profit margin was 29.51%, which is an increase of 8.35 percentage points compared to the same period last year [1] Operating Expenses - Operating expenses for the first three quarters amounted to 78.22 million yuan, an increase of 3.96 million yuan year-on-year [1] - The operating expense ratio was 32.08%, a decrease of 4.67 percentage points from the previous year [1] - Sales expenses increased by 20.04%, management expenses rose by 8.16%, and R&D expenses grew by 16.47%, while financial expenses decreased by 251.22 thousand yuan [1] Leadership Compensation - The chairman and the general manager of the company, Chen Wangyu and Chen Wangdong, received a salary of 1.104 million yuan each in 2024 [3] Shareholding Structure - The controlling shareholders, Chen Wangyu and Chen Wangdong, are brothers, holding 25.85% and 25.79% of the shares respectively [4] Company Background - The company, Tianchen Medical, is located in Suzhou Industrial Park, Jiangsu Province, and was established on August 18, 2003 [7] - It specializes in the research, innovation, production, and sales of high-end surgical staplers [7]